Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print

Latest Articles in glenmark

HUL Completes Acquisition Of Female Hygiene Brand Vwash From Glenmark

The shares of HUL were trading at Rs 2,149 apiece on BSE, down 1.15 per cent from their previous close.

Read More

Anti-viral Drug Favipiravir Shows Clinical Improvement In Mild, Moderate COVID-19 Cases: Glenmark

However, it said that pregnant and lactating mothers were not included in the clinical trial.

Read More

Anti-viral drug favipiravir gets DGCI nod for 'restricted emergency use' in mild to moderate COVID-19 cases

Anti-viral drug favipiravir gets DGCI nod for 'restricted emergency use' in mild to moderate COVID-19 cases

Read More

Glenmark To Conduct Trials In India For Potential COVID-19 Drug

Glenmark will initially enroll 150 patients with mild-to-moderate COVID-19 in a randomized trial that will compare favipiravir with standard supportive care.

Read More

HUL Share Price Jumps 8 Pc After Acquiring Vwash Brand From Glenmark

HUL is India's largest fast-moving consumer goods (FMCG) company with its products touching the lives of nine out of ten households in the country.

Read More

Dr Reddy’s, Sun Pharma, Glenmark Face US price Fixing Charge

The states are seeking to expand the complaint to include Actavis Holdco US, Actavis Pharma, Ascend Laboratories, Apotex Corp, Dr Reddy’s Laboratories (DRL), Emcure Pharmaceuticals, Glenmark Pharmaceuticals, Lannett Company, etc.

Read More

Glenmark Pharma: A Healthy Dose Of Growth

Glenmark, which has graduated to a global organisation in a very short span with its expanded manufacturing footprint, international operations and global employee base, reported a 276.08 per cent rise in revenue since 2012

Read More

Glenmark Stock Up After US Approval To Its Savella Generic

Shares of drug maker Glenmark Pharmaceuticals rose 0.52 per cent to Rs 868. 45 a unit on BSE on Friday, a day that saw the benchmark Sensex down by at least 50 points

Read More

Glenmark, Evestra To Jointly Develop And Sell NuvaRing Copy In US

Drug maker Glenmark and Evestra Inc, a San Antonio-based biopharmaceutical research and development company with focus in women’s healthcare, have signed a licensing and commercialization agreement for development and marketing of a generic version of Merck & Co.’s NuvaRing, for the US market

Read More

Glenmark Gets US Approval For Banzel Generic With 6-Month Exclusivity

The company said it is eligible for 180 days of shared generic drug marketing exclusivity for rufinamide tablets

Read More

Pharmaceutical Sector Grows 12 Per Cent In February: Report

Domestic companies grew at a modest pace of 14 per cent as against 19.4 per cent in the same period last year, and an average of 13.3 per cent since April 2015

Read More

Glenmark Q3 Net Up 48 Per Cent On Robust US, India Sales

While the company's US business grew about 20 per cent to Rs 608.86 crore, the India business posted a growth of 12.69 per cent to Rs 488 crore during the quarter

Read More